Results 221 to 230 of about 98,699 (349)

Characterisation of sleep apneas and respiratory circuitry in mice lacking CDKL5

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary CDKL5 deficiency disorder is a rare genetic disease caused by mutations in the CDKL5 gene. Central apneas during wakefulness have been reported in patients with CDKL5 deficiency disorder. Studies on CDKL5‐knockout mice, a CDKL5 deficiency disorder model, reported sleep apneas, but it is still unclear whether these events are central (central ...
Gabriele Matteoli   +12 more
wiley   +1 more source

Early sleep apnea treatment in stroke (eSATIS) – a multicentre, randomised controlled, rater‐blinded, clinical trial: The association of post‐stroke cognition with sleep‐disordered breathing and its treatment

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Sleep‐disordered breathing (SDB) is linked to cognitive dysfunction. Although SDB is common in stroke patients, the impact of SDB and its early treatment on cognitive functioning after stroke remains poorly investigated. Therefore, we explored the association between SDB and post‐stroke cognitive functioning, including the impact of early SDB ...
Irina Filchenko   +9 more
wiley   +1 more source

Changes in Upper Airway Size during Tidal Breathing in Children with Obstructive Sleep Apnea Syndrome

open access: green, 2005
Raanan Arens   +7 more
openalex   +1 more source

Decrease of excessive daytime sleepiness after shunt treatment for normal pressure hydrocephalus

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Sleepiness and apathy are often reported in patients with normal pressure hydrocephalus. However, research on outcomes after shunt surgery has mainly focused on the classical triad symptoms, that is, gait, cognition, and bladder dysfunction. This study aimed to describe the effects of shunt treatment on excessive daytime sleepiness and whether ...
Simon Lidén   +4 more
wiley   +1 more source

Blood Pressure “Dipping” and “Non-Dipping” in Obstructive Sleep Apnea Syndrome Patients [PDF]

open access: bronze, 1996
Mayumi Suzuki   +3 more
openalex   +1 more source

Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng   +3 more
wiley   +1 more source

Three Decades of Managing Pediatric Obstructive Sleep Apnea Syndrome: What's Old, What's New. [PDF]

open access: yesChildren (Basel)
Panetti B   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy